Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cutaneous vasculitis disclosing pulmonary tuberculosis].

V Martinez1, V Zeller, E Caumes

  • 1Département des Maladies Infectieuses et Tropicales, Groupe Hospitalier Pitié-Salpêtrière, 47-83, boulevard de l'Hôpital, 75651 Paris Cedex 13.

Annales De Medecine Interne
|February 15, 2001
PubMed
Summary

Leukocytoclastic vasculitis can be caused by active pulmonary tuberculosis. Treating the infection alone resolved the vasculitis, indicating no need for immunosuppressants.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Uptake of drug-reduced antiretroviral strategies and impact on costs over 2015-22: experience from an HIV clinic in Paris, France.

The Journal of antimicrobial chemotherapy·2025
Same author

No virological failure in patients living with HIV with past NNRTI resistance-associated mutations switched to doravirine-containing regimens.

The Journal of antimicrobial chemotherapy·2025
Same author

A case series of intermittent nucleoside analogue-based (NA) regimen to maintain HBV virological suppression in coinfected HBV/HIV patients with suppressed viremia.

Infectious diseases now·2024
Same author

The burden of secrecy in the management of multimorbidity in older people living with HIV aged 70 and over.

AIDS care·2024
Same author

Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies.

HIV medicine·2024
Same author

Comparison of HIV-Infected and Noninfected Patients Undergoing Bariatric Surgery: The ObeVIH Study.

Journal of acquired immune deficiency syndromes (1999)·2022

Area of Science:

  • Pulmonology
  • Rheumatology
  • Infectious Diseases

Background:

  • Vasculitis, particularly leukocytoclastic vasculitis, can present with diverse underlying causes.
  • Tuberculosis (TB) is a significant infectious disease globally, with potential extrapulmonary manifestations.
  • The association between vasculitis and tuberculosis is infrequently reported.

Observation:

  • A case study involving a patient presenting with leukocytoclastic vasculitis was observed.
  • The patient exhibited active pulmonary tuberculosis but showed no overt signs of systemic vasculitis.
  • The clinical presentation and diagnostic findings pointed towards a TB-induced vasculitic process.

Findings:

  • The patient's leukocytoclastic vasculitis resolved favorably solely with anti-tuberculosis treatment.

Related Experiment Videos

  • No recurrence of vasculitis was noted at an 8-month follow-up period.
  • Immunosuppressive therapy was not required for the management of the vasculitis.

    • Implications:

    • This case highlights that tuberculosis should be considered in the differential diagnosis of vasculitis, even without systemic signs.
    • Effective treatment of the underlying tuberculosis infection can lead to the remission of associated vasculitis.
    • The findings suggest that immunosuppressors may not be necessary, simplifying treatment protocols for TB-associated vasculitis.